Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

See all formats and pricing
More options …
Volume 39, Issue 3


Prognostic Significance of the Presence of Erythroblasts in Blood after Cardiothoracic Surgery

Axel Stachon / Andreas Böning / Michael Krismann / Heike Weisser / Axel Laczkovics / Guido Skipka / Michael Krieg
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2001.038


In patients suffering from a variety of severe diseases the detection of erythroblasts in peripheral blood is associated with poor prognosis. However, as yet the prognostic significance of erythroblasts in the blood of patients after cardiothoracic surgery has not been assessed. In a retrospective study we analyzed the database of 2074 patients, of whom 87 died in hospital during the postoperative period. All patients underwent cardiothoracic surgery using a heart-lung machine. Together with erythroblasts in blood, age, sex, body mass index, preoperative ejection fraction, smoking, diabetes mellitus, type of operation, emergency surgery, renal deficiency, pulmonary hypertension, and endocarditis were considered. The postoperative mortality of patients with erythroblasts in peripheral blood (n=57) was 45.6% (n=26), being significantly higher (p﹤0.001) than the mortality of patients without erythroblasts (3.0%). None of six patients with more than 2000 erythroblasts x 106/l survived. The postoperative detection of erythroblasts is highly predictive of death, the odds ratio after adjustment for the other known prognostic factors being 7.2 (95% confidence interval 3.4–15.1). Erythroblasts were detected for the first time on average 11 ±2 days (median: 7 days; n=57) after surgery and 8 ±2 days (median: 6 days; n=26) before death. The detection of erythroblasts in blood after cardiothoracic surgery has a high prognostic significance in terms of in-hospital mortality, helping physicians to identify patients at high risk of death. This finding has to be confirmed by a prospective study with the use of a more sensitive and reliable technology and prospectively defined time intervals for counting blood cells.

About the article

Published Online: 2005-06-01

Published in Print: 2001-04-09

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 39, Issue 3, Pages 239–243, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2001.038.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Andrew V. Kossenkov, Noor Dawany, Tracey L. Evans, John C. Kucharczuk, Steven M. Albelda, Louise C. Showe, Michael K. Showe, Anil Vachani, and Rui Medeiros
PLoS ONE, 2012, Volume 7, Number 3, Page e34392
Borros M. Arneth and Mario Menschikowki
Journal of Clinical Laboratory Analysis, 2015, Volume 29, Number 3, Page 175
Axel Stachon, Nina Sondermann, Matthias Imohl, and Michael Krieg
Journal of Laboratory and Clinical Medicine, 2002, Volume 140, Number 6, Page 407
Axel Stachon, Reiner Kempf, Tim Holland-Letz, Jochen Friese, Andreas Becker, and Michael Krieg
Clinica Chimica Acta, 2006, Volume 366, Number 1-2, Page 329
Sandra Kuert, Tim Holland-Letz, Jochen Friese, and Axel Stachon
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 2
Axel Stachon, Tim Holland-Letz, Reiner Kempf, Andreas Becker, Jochen Friese, and Michael Krieg
Clinical Chemistry and Laboratory Medicine (CCLM), 2006, Volume 44, Number 8
Axel Stachon, Elmar Segbers, Steffen Hering, Reiner Kempf, Tim Holland-Letz, and Michael Krieg
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 6
Axel Stachon, Andreas Becker, Reiner Kempf, Tim Holland-Letz, Jochen Friese, and Michael Krieg
The Journal of Trauma: Injury, Infection, and Critical Care, 2008, Volume 65, Number 3, Page 666
A. Stachon, A. Becker, T. Holland-Letz, J. Friese, R. Kempf, and M. Krieg
European Surgical Research, 2008, Volume 40, Number 3, Page 263

Comments (0)

Please log in or register to comment.
Log in